Research Article
Active Transport and Health Outcomes: Findings from a Population Study in Jiangsu, China
Table 3
Health outcomes/indices and frequency and duration of AT.
| | Frequency (days/week) | Daily duration (minutes/day) | | 1-2 | 3–6 | 7 | <30 | 30–60 | >60 |
| Obesity (%) | 13.63 | 12.85 | 14.58 | 10.70 | 14.53 | 15.12 | Central obesity (%) | 41.43 | 41.08 | 44.50 | 41.09 | 42.32 | 44.68 | Hypertension (%)*† | 48.02 | 48.99 | 53.02 | 45.81 | 50.19 | 54.84 | Diabetes (%) | 7.61 | 7.21 | 10.03 | 7.34 | 9.50 | 8.86 | Cholesterol disorder (%)† | 31.38 | 33.81 | 35.55 | 29.66 | 35.01 | 36.50 | BMI (cm) | 24.11 | 24.31 | 24.44 | 24.06 | 24.43 | 24.44 | WC (cm)* | 81.96 | 82.07 | 82.92 | 81.67 | 82.59 | 82.91 | SBP (mmHg)† | 138.97 | 138.78 | 139.53 | 135.70 | 139.86 | 140.64 | DBP (mmHg) | 84.42 | 84.78 | 84.98 | 83.87 | 85.35 | 84.89 | FBG (mmol/L) | 5.55 | 5.53 | 5.72 | 5.60 | 5.62 | 5.66 | TC (mmol/L)* | 4.38 | 4.36 | 4.37 | 4.39 | 4.40 | 4.32 | HDL-C (mmol/L)† | 1.35 | 1.32 | 1.31 | 1.35 | 1.31 | 1.31 | LDL-C (mmol/L) | 2.22 | 2.25 | 2.30 | 2.26 | 2.30 | 2.25 | TG (mmol/L) | 1.44 | 1.42 | 1.61 | 1.48 | 1.55 | 1.53 |
|
|
*
P < 0.05 between different groups of frequency; †P < 0.05 between different groups of daily duration.
|